How to Customize TPN Formulas for Individual Patient Needs

August 25, 2025

Introduction

Total Parenteral Nutrition (TPN) plays a pivotal role in patient care when the gastrointestinal tract is unable to process food. Given this reliance on intravenous nutrition, understanding how to customize TPN formulas for individual patients becomes crucial. This article explores the components of TPN solutions, methods of customization based on patient needs, guidelines for writing TPN orders, and strategies for effective administration and troubleshooting.

Understanding the Components of TPN

What are the components of a TPN solution?

Total parenteral nutrition (TPN) is a pivotal therapy for patients who cannot utilize their gastrointestinal tract effectively. It consists of a carefully balanced mixture that incorporates several vital components:

  • Amino Acids : Essential for protein synthesis, tailored to support the individual’s metabolic needs.
  • Dextrose : A primary carbohydrate source providing immediate energy.
  • Lipid Emulsions : These deliver essential fatty acids and serve as a concentrated energy source.
  • Electrolytes : Customize based on lab results, particularly important for patients with renal issues.
  • Vitamins and Minerals : Ensure that all micronutrient requirements are met, enhancing overall health.
  • Trace Elements : Important for various biochemical processes, adjusted according to individual needs.
  • Medications : Such as insulin or anticoagulants may be added to address specific conditions.

The complete formulation is designed to meet the patient's caloric and nutrient demands, monitored continuously to prevent complications like refeeding syndrome.

Role of healthcare professionals in TPN preparation

The preparation and administration of TPN is a collaborative effort among healthcare professionals. Here’s how these experts contribute:

  • Physicians : Approve the treatment plan and order the necessary lab tests.
  • Dietitians : Assess nutritional needs and formulate the TPN order based on individual requirements, considering factors like body weight, clinical conditions, and basal metabolic rate.
  • Pharmacists : Provide guidance on medication compatibility and contribute to the formulation of the TPN solution to ensure it meets the patient's therapeutic needs.
  • Nurses : Administer the TPN and monitor for any adverse reactions or complications. They track vital signs, serum electrolytes, and overall patient status.

Together, this multidisciplinary team ensures that TPN is customized effectively for every patient, fostering a safe and efficient delivery of nutrition directly to the bloodstream.

Component Purpose Customization
Amino Acids Protein synthesis and repair Based on metabolic needs
Dextrose Energy source Adjusted for caloric needs
Lipid Emulsions Essential fatty acids Tailored to patient condition
Electrolytes Maintain biochemical balance Monitored based on lab results
Vitamins & Minerals Support immune function Customized per deficiencies
Medications Manage specific medical conditions Added as needed

Customizing TPN for Individual Patient Needs

How are TPN solutions customized to meet individual patient needs?

Customizing Total Parenteral Nutrition (TPN) solutions is a pivotal aspect of nutritional therapy when a patient's gastrointestinal function is impaired. The composition of TPN varies to address individual medical conditions and requirements. This tailored approach encompasses both macronutrients and micronutrients.

For macronutrients, the healthcare team carefully adjusts the ratios of carbohydrates, proteins, and fats. For example, critically ill patients may require protein levels around 1.5 gm/kg/day, while those with chronic renal failure might need only 0.6 to 0.8 gm/kg/day. Dextrose concentrations are modified to ensure adequate caloric provision, while lipid emulsions are included to support metabolic needs.

Micronutrients such as vitamins, electrolytes, and trace elements also play a vital role. These are selected based on individual patient blood work and specific deficiencies to avoid complications, including refeeding syndrome. Monitoring serum electrolytes and other lab results allows for informed adjustments to the TPN formulation, ensuring it meets the patient's evolving needs.

Role of interdisciplinary teams in personalization

The personalization of TPN isn't a solo effort; it involves a robust interdisciplinary team. This typically includes physicians, dietitians, pharmacists, and nursing staff. Together, they assess the patient’s health history, laboratory results, and nutritional requirements to construct an effective TPN formula.

Dietitians are particularly crucial in calculating the macronutrient breakdown, beginning with protein needs before determining the amounts of lipids and dextrose necessary for the total caloric intake. Regular communication across disciplines ensures that any changes in the patient’s condition prompt immediate adjustments to the TPN, enhancing patient safety and nutritional effectiveness.

Moreover, the collaborative nature of this process addresses potential complications by employing best practices, such as adjusting infusion rates and determining appropriate venous access. By following stringent protocols and utilizing each team member's expertise, healthcare professionals can vastly improve the TPN experience and outcomes for patients requiring intravenous nutrition.

Aspect of TPN Customization Specific Adjustments Involved Team Members
Macronutrient Composition Adjust protein, lipids, and dextrose Physicians, Dietitians
Micronutrient Inclusion Tailor vitamins and trace elements Pharmacists, Dietitians
Monitoring and Adjustment Daily weight, lab results analysis Nursing Staff, Physicians

This comprehensive and customized approach is essential in ensuring that TPN not only replaces missing nutrition but also supports recovery and overall health effectively.

Calculating Nutritional Needs for TPN

How do you calculate nutritional needs for TPN?

To calculate nutritional needs for Total Parenteral Nutrition (TPN), healthcare professionals begin by establishing a total fluid goal. One effective method is the Holliday-Segar method, which takes into account the patient's age, weight, and clinical condition.

Next, the energy requirements are assessed. Generally, energy needs are about 10-15% lower for patients on parenteral nutrition than those receiving enteral feeding. Utilizing equations like the Harris-Benedict formula helps estimate basal energy expenditure accurately.

The macronutrient breakdown is fundamental in TPN formulation, with recommended distributions typically around:

Macronutrient Percentage of Total Calories Recommended Intake
Carbohydrates 45-60% 3-5 mg/kg/min
Proteins 10-15% 1.5 gm/kg/day (critically ill)
Fats 25-40% Start with 1 gm/kg/day, adjust accordingly

Importance of baseline labs and continuous monitoring

Obtaining baseline lab values is crucial before initiating TPN to understand the patient's metabolic needs. Essential tests include a Basic Metabolic Profile, liver function tests, and assessments for electrolytes. Monitoring these values continuously allows for safe nutrient delivery, as TPN formulations can be adjusted based on ongoing lab results.

Daily observations of patient parameters such as weight, blood glucose levels, and vital signs also play a significant role in managing TPN effectively. In malnourished patients, it is particularly important to start with conservative protein and caloric goals to prevent refeeding syndrome.

In conclusion, the precision in calculating nutritional needs for TPN relies on layered assessments, starting with accurate energy requirements and careful consideration of macronutrient ratios, followed by thorough monitoring to ensure optimal patient outcomes.

Guidelines for Writing TPN Orders

What are the guidelines for writing TPN orders?

Writing Total Parenteral Nutrition (TPN) orders requires a structured approach to ensure patient safety and nutritional adequacy. The first step is to confirm clear indications for TPN, typically indicated when the gastrointestinal tract is non-functional or when significant nutritional deficiencies cannot be corrected through enteral feeding after five days.

A thorough evaluation of the patient's nutritional status is essential. Key components to assess include:

  • Anthropometric Data : Actual height and weight must be measured and used to calculate Ideal Body Weight (IBW) to guide nutritional needs.
  • Laboratory Values : Baseline labs, including Basic Metabolic Profile, electrolytes, liver function tests, and Prealbumin, help establish a patient’s metabolic state and guide adjustments in nutrient composition.
  • Medical History : Understanding the patient's health background is crucial for tailoring the TPN formulation.

Once all data is gathered, clinicians should focus on the macronutrient composition of the TPN to meet metabolic requirements. This involves accurately calculating the required amount of carbohydrates, proteins, and fats tailored to individual needs. For instance, critically ill patients may require higher protein levels compared to those with chronic renal failure.

Collaborative approach in order writing

The formulation of TPN orders is a collaborative effort that involves a multidisciplinary healthcare team, ensuring that each patient's unique needs are met. This team may include:

  • Physicians : They provide clinical oversight and guide the overall management strategy.
  • Dietitians : Responsible for calculating macronutrient breakdown and ensuring the nutritional adequacy of the TPN formula.
  • Nurses : Monitor patient response to TPN and perform critical checks, such as monitoring blood glucose and serum electrolytes.
  • Pharmacists : Consult on medication interactions and ensure compatibility of additional additives with the TPN bag.

Monitoring post-initiation is crucial. Regular checks for glucose control, weight, intake and output, and adjustments based on lab results are necessary to minimize risks, such as refeeding syndrome. Starting conservatively with TPN, especially in malnourished patients, allows for safer increases in caloric delivery and macronutrient adjustments as needed.

Managing TPN Infusion Rates

What influences infusion rates for TPN?

Infusion rates for Total Parenteral Nutrition (TPN) are influenced by various factors including the patient’s medical condition, nutritional needs, and the method of administration. It is vital to start with a conservative approach, administering no more than 50% of the calculated energy needs initially. This reduces the risk of complications, particularly in malnourished patients, who may require a gradual increase in intake over time.

Specifically, the glucose infusion rate should generally remain within 5 to 7 mg/kg/min to mitigate the risk of hyperglycemia. Factors such as the patient's electrolyte balance, fluid needs, and current lab results also play essential roles in determining the infusion rate. Healthcare teams need to consider the degree of the patient's stress response and their overall nutritional deficits when setting TPN rates.

How is TPN monitored and adjusted?

Monitoring TPN involves regular assessment of laboratory values, including serum electrolytes and liver function tests. Daily checks of the patient’s weight, blood glucose levels (Accuchecks), and fluid intake/output (I&Os) are crucial for successful nutritional management.

Adjustments to TPN should be made based on daily evaluations, particularly in the first week of administration. If a patient exhibits stability in their electrolytes, macronutrient delivery can be modified accordingly. Additionally, monitoring using indirect calorimetry can provide accurate measurements of resting energy expenditure, further refining TPN customization.

In summary, while infusing TPN, it is important to comply with orders submitted prior to 3 PM to allow for a continuous infusion over 24 hours, thereby minimizing contamination risks and ensuring safe patient outcomes.

Adjustments in Adult TPN Dosing

What are common adjustments necessary for TPN dosing in adults?

Total Parenteral Nutrition (TPN) is a complex therapy necessitating precise adjustments tailored to each patient's individual health needs. The first significant area of adjustment involves the protein and macronutrient requirements. Protein needs can greatly differ based on the patient’s clinical status.

  • Critically Ill Patients: Typically require 1.5 g/kg/day of protein.
  • Stable Patients (e.g., those with chronic renal failure): May need only 0.6 to 0.8 g/kg/day.

As with proteins, other macronutrients also require similar individual assessment and adjustment. Dextrose, when provided, should never exceed a rate of 5 mg/kg/minute to mitigate the risk of hyperglycemia. For lipid emulsions, the dosing guidelines also vary: critically ill patients might need as much as 1.5 g/kg/day, whereas more stable individuals may require only 1 g/kg/day.

How should electrolytes be assessed and modified in TPN?

Electrolyte management is another crucial aspect of TPN therapy. Electrolyte dosing must be customized based on ongoing evaluation of the patient's serum electrolyte levels. Here are some common recommendations:

  • Sodium: Approximately 100-150 mEq/day.
  • Potassium: Generally ranges from 50-100 mEq/day.
  • Calcium and Magnesium: Should also be carefully monitored and adjusted according to lab findings.

In patients with renal impairments or other specific conditions, further modifications may be necessary. Continuous monitoring allows for timely adjustments, ensuring that patients receive an adequate balance of nutrients while minimizing the risk of complications such as electrolyte imbalances and refeeding syndrome. Regular checks, lab results, and individualized formulas are key to optimal TPN delivery.

Troubleshooting TPN Complications

How do you handle complications or troubleshoot issues in TPN administration?

Complications during Total Parenteral Nutrition (TPN) administration can occur, and prompt identification is vital for patient safety. Regular monitoring is essential to recognize signs such as:

  • Hyperglycemia: Elevated blood sugar levels requiring adjustments to carbohydrate content.
  • Electrolyte Imbalances: Sudden changes in electrolyte levels can lead to serious health complications.
  • Referring Syndrome: A condition that may arise when reintroducing nutrition, particularly in malnourished patients.

If any abnormal symptoms develop, such as fever, confusion, or unusual changes in vital signs, it is crucial to contact the healthcare provider immediately.

Solutions and preventive measures

To effectively manage these complications, certain strategies should be employed:

  1. Maintain Aseptic Techniques: This is vital to prevent infections, a significant risk during TPN administration.
  2. Routine Monitoring: Regular checks of blood glucose, electrolytes, and other laboratory results must be integrated into patient care to effectively manage their nutritional status.
  3. Patient Symptoms Tracking: Keep an eye on signs like fever or confusion, which may indicate underlying complications needing immediate attention.
  4. Proper Flushing Techniques: Before and after TPN infusion, ensure the central line is properly flushed to maintain catheter patency and reduce the risk of blockage or infection.

Lastly, employing multidisciplinary collaboration among clinicians, dietitians, and pharmacists empowers the tailoring of TPN therapy to meet individual needs efficiently.

Complication Symptoms Preventive Measures
Hyperglycemia Elevated blood sugar levels Adjust carbohydrate content in TPN mix
Electrolyte Imbalance Abnormal electrolyte levels Routine electrolyte monitoring
Refeeding Syndrome Fatigue, confusion, gastrointestinal issues Gradual increase in calories and protein

By focusing on these strategies, the healthcare team can enhance patient outcomes and minimize TPN-related complications.

Role of Comprehensive Monitoring in TPN

Importance of laboratory and clinical monitoring

Monitoring patients on Total Parenteral Nutrition (TPN) is crucial to ensure safety and effectiveness. Regular assessments of serum electrolytes, liver function tests, and urine sugar levels allow healthcare teams to tailor the nutrient composition according to the patient’s specific demands.

Baseline lab tests, such as the Basic Metabolic Profile and liver function tests, are essential for evaluating initial nutritional requirements. These lab results, along with the patient's health history and daily weight, guide the TPN formulation and adjustments.

Adjusting based on patient progress

As patients progress on TPN, clinicians must modify macronutrient delivery based on daily observations. For instance, malnourished patients may require gradual increases in protein and caloric intake to mitigate risks like refeeding syndrome. Monitoring is also essential to prevent complications such as hyperglycemia and electrolyte imbalances.

In summary, maintaining a close eye on clinical data allows for agile adjustments in TPN therapy, ensuring each patient receives optimal nourishment tailored to their needs.

Medical Conditions Necessitating TPN Customization

Impact of renal and hepatic impairments

Certain medical conditions, particularly renal and hepatic impairments, necessitate a careful approach to Total Parenteral Nutrition (TPN) customization. For individuals with chronic renal failure, the protein intake must be reduced to about 0.6 to 0.8 g/kg/day, while critically ill patients might require significantly more at around 1.5 g/kg/day.

Electrolyte and trace element adjustments are crucial for these patients as well. Regular monitoring of serum electrolytes assists clinicians in tailoring the TPN composition to prevent complications. This customized strategy ensures that patients receive adequate nutrients while avoiding exacerbation of their underlying conditions.

Tailoring based on metabolic and caloric demands

Each patient's metabolic and caloric requirements must be uniquely assessed to formulate an appropriate TPN plan. By utilizing indirect calorimetry calculations of resting energy expenditure, healthcare teams can tailor the composition to meet individual needs more precisely.

Additionally, initial TPN orders often start conservatively to mitigate risks, particularly in malnourished patients who may require gradual increases in protein and caloric intake post-administration. This individualized approach ensures that patients receive nutrients in a way that aligns with their specific health status and metabolic requirements.

Patient Condition Macronutrient Needs (g/kg/day) Considerations
Chronic Renal Failure 0.6 to 0.8 Adjust electrolytes regularly
Critically Ill Patients 1.5 Higher protein for recovery
Malnourished Patients Gradual increase starting at 1/3 Risk of refeeding syndrome after initiation

The Pharmacist’s Role in TPN Therapy

Drug-nutrient interactions in TPN

The involvement of pharmacists in Total Parenteral Nutrition (TPN) therapy is essential for ensuring the safe and effective administration of nutrients. One critical aspect is managing drug-nutrient interactions. Certain medications can alter nutrient absorption or metabolism, potentially leading to complications. For example, medications that affect electrolyte levels must be carefully monitored and adjusted in TPN formulations.
Pharmacists evaluate compatibility of medications added to the TPN bag, advising on best practices to avoid precipitate formation and ensuring optimal delivery of both nutrients and pharmaceuticals.

Cost considerations and role in therapy

Cost efficiency is another important aspect of TPN therapy that pharmacists help navigate. Due to the complexities involved in TPN customization, costs can vary significantly based on patient needs and the ingredients used. Pharmacists can provide cost-effective recommendations, taking into account patient-specific factors and resources. Their expertise ensures that patients receive all necessary nutrients without incurring unnecessary expenses, thereby enhancing the overall quality of care.

Additionally, collaborating with dietitians and clinicians, pharmacists help in streamlining TPN orders, preventing waste, and advocating for the appropriate use of resources in managing TPN therapy.

Ensuring Quality and Safety in TPN Administration

Maintaining aseptic conditions and protocols

When administering Total Parenteral Nutrition (TPN), maintaining strict aseptic conditions is crucial. This includes proper hand hygiene, using sterile techniques during the preparation of the TPN bag, and ensuring that the TPN solution does not contain any particles or crystals. Regular inspections of the TPN bag are necessary to confirm the integrity and cleanliness of the solution before administration. Such protocols help in minimizing infection risks, which are critical in patients receiving TPN due to their compromised health status.

Importance of timely order submission and infusion management

Timely submission of TPN orders is essential. It is recommended that orders are submitted before 3 PM daily to allow pharmacy to prepare the solution adequately. Furthermore, TPN should be infused over a 24-hour period to prevent contamination. Effective coordination between healthcare professionals, including doctors and pharmacists, enhances patient safety and aligns the TPN administration with daily monitoring of patient condition. This thorough management ensures that adjustments can be made based on laboratory results, thus optimizing nutritional support.

Reimbursement Considerations for TPN Therapy

How is TPN coded for reimbursement?

Total parenteral nutrition (TPN) is coded for reimbursement using specific HCPCS codes which vary based on the volume administered. The primary code for TPN, when administering between one to two liters per day, is S9366 . This code not only covers the infusion itself but also includes necessary administrative services, professional pharmacy services, care coordination, and related supplies essential for the therapy.

For patients requiring more than two liters but no more than three liters each day, the appropriate code is S9367 . Similar to S9366, this code encompasses a comprehensive range of services to ensure effective patient care. It's important to note that certain medications administered during TPN may need separate billing, ensuring all aspects of care are adequately covered.

How does TPN affect healthcare resource management?

TPN therapy impacts healthcare resource management significantly by requiring detailed planning and coordination among healthcare teams. Effective management focuses on personalized patient care, cost efficiency, and optimized resource allocation. Close monitoring and daily assessments are vital, as they guide necessary adjustments, support safe administration, and facilitate timely reimbursements based on thorough coding practices, ensuring all services rendered are justifiably documented and compensated.

Conclusion

Successfully implementing Total Parenteral Nutrition requires a nuanced understanding of the various ingredients and how they interact with individual patient conditions. Customized TPN can greatly improve patient outcomes when oral or enteral nutrition isn't viable. By focusing on precise calculations, guidelines adherence, and collaborative healthcare efforts, practitioners can ensure that patients receive the nutrition necessary for recovery and wellbeing. Continuous monitoring and adaptability are key in effectively managing TPN and preventing potential complications.

References

Home Infusion Therapy in New York
June 17, 2026
Pharmko is based in New York and provides home infusion therapy statewide — IV antibiotics, IVIG, TPN, IDPN, and specialty medications. Licensed, ACHC accredited, and available 24/7.
Home Infusion for Osteomyelitis
June 15, 2026
Osteomyelitis requires weeks of IV antibiotics that can often be completed at home. Learn who qualifies for OPAT, what the treatment timeline looks like, and how Pharmko supports bone infection recovery.
What Is a PICC Line
June 15, 2026
Learn what a PICC line is, how it's inserted, how to care for it at home, and why it's the most common IV access device for home infusion therapy. Pharmko nurses provide full PICC line training.
IV Iron Infusion at Home: Feraheme, Injectafer, and Iron Deficiency Anemia Treatment
June 12, 2026
Learn how IV iron infusion works at home — which products are used, who qualifies, what to expect during treatment, and how Pharmko delivers iron infusion therapy across 22+ states.
Home Infusion for Multiple Sclerosis
June 11, 2026
Learn how home infusion therapy works for multiple sclerosis, including Ocrevus and Tysabri, who qualifies for home-based MS infusions, what to expect, and how Pharmko coordinates care.
TPN at Home: Who Qualifies, How It Works, and What to Expect
June 11, 2026
Learn how total parenteral nutrition (TPN) at home works — who qualifies, how it's delivered, what daily life looks like, and how Pharmko supports patients from first dose through long-term therapy.
Low Albumin in Dialysis Patients
June 3, 2026
Low albumin is a key marker of malnutrition in dialysis patients. Learn what causes albumin decline, when IDPN is indicated, and how Pharmko supports renal nutrition across 22+ states.
Home Infusion Pump Types
June 2, 2026
Learn about the different types of infusion pumps used in home therapy, ambulatory, electronic, elastomeric, and CADD pumps, and how your pump is matched to your specific treatment.
Home Infusion for Rheumatoid Arthritis
May 30, 2026
Learn how home infusion therapy works for rheumatoid arthritis — including Remicade (infliximab) and other IV biologics, who qualifies for home treatment, and how Pharmko supports ongoing RA care.
Sterile Compounding Safety
May 26, 2026
When a patient or provider chooses a compounding pharmacy to prepare IV medications, they are trusting that the pharmacy operates under rigorous, independently enforced standards. In the United States, those standards are defined by two chapters of the United States Pharmacopeia: USP <797> for sterile compounding and USP <800> for hazardous drug handling. Pharmko operates in full compliance with both chapters. Understanding what these standards require, and what happens when they are not met, helps patients and providers make informed decisions about which pharmacy they trust with their care. What Is USP <797>? USP <797> (Pharmaceutical Compounding, Sterile Preparations) is the national standard that defines the minimum requirements for compounding sterile preparations safely. It covers: Cleanroom environment classification, ISO Class 5 at the point of compounding, ISO Class 7 for the surrounding buffer area, ISO Class 8 for the ante-room Personnel training, gowning, and aseptic technique requirements Sterilization and filtration methods by product type Beyond-use dating (BUD), how long a compounded sterile preparation remains safe to use Environmental and personnel monitoring schedules Quality assurance, documentation, and deviation management USP <797> applies to every pharmacy that prepares IV solutions, injections, eye drops, or other sterile preparations, whether they are a hospital pharmacy, ambulatory infusion center, or specialty pharmacy like Pharmko. The 2023 Revision: What Changed USP <797> was significantly revised in 2023 (effective November 2023). Key changes include: Stricter beyond-use date requirements, compounded sterile preparations must now meet more conservative dating limits unless sterility testing supports extended dating Enhanced environmental monitoring, more frequent air and surface sampling with defined action levels Clearer personnel qualification requirements, competency assessments are now required at defined intervals New category system, preparations are now categorized (Category 1 and Category 2) based on sterility assurance level and BUD Pharmacies that were compliant under the previous version of USP <797> must have updated their procedures and infrastructure to meet the 2023 revision. Pharmko updated our facilities, policies, and documentation systems in alignment with the revised chapter. What Is USP <800>? USP <800> (Pharmaceutical Compounding, Hazardous Drugs) establishes standards for the safe handling of hazardous drugs throughout the pharmacy, from receipt and storage to preparation, dispensing, and waste disposal. Hazardous drugs include certain chemotherapy agents, antiviral medications, hormones, and other drugs that pose risks of carcinogenicity, reproductive toxicity, or organ damage at low exposure levels. USP <800> requires: Negative-pressure ventilated containment primary engineering controls (C-PECs) for hazardous drug compounding Separate, dedicated hazardous drug storage areas Personal protective equipment (PPE) requirements for all staff handling hazardous drugs Closed-system drug transfer devices (CSTDs) for certain preparations Spill kits and exposure management protocols Why These Standards Matter for Patients The consequences of non-compliance are serious. High-profile compounding pharmacy failures, including a 2012 fungal meningitis outbreak linked to contaminated steroid injections that killed 64 patients and injured hundreds, demonstrated what happens when sterile compounding standards are not followed. For patients receiving home IV therapy, USP <797> compliance is not a credential to check once and forget, it reflects the ongoing daily practices of the pharmacy preparing their medications. Patients and providers should verify that any pharmacy preparing their IV solutions is accredited, state-licensed, and actively compliant with current USP standards. How Pharmko Meets These Standards Pharmko's sterile compounding facility is designed, staffed, and operated to meet USP <797> and USP <800> requirements. We are ACHC accredited, state-licensed in 22+ states, and subject to regulatory inspection. Every batch we compound is reviewed by a licensed pharmacist, and our environmental and personnel monitoring data is reviewed on a defined schedule. For a broader overview of what sterile compounding is and how it differs from retail pharmacy, see our guide on what is sterile compounding for IV therapy . For providers interested in our compounding capabilities, see our physician services page or contact our pharmacy team directly. → Contact Pharmko about sterile compounding: 1-877-540-2003
Show More